10-Q: Yijia Group Q2 2026: Revenue Surges, Net Income Rises

Yijia Group Corp. reported a significant increase in revenue and gross profit for the three and six months ended October 31, 2025, driven by its dietary supplement segment, despite identifying material weaknesses in internal controls.

Summary

• Revenue for the three months ended October 31, 2025, increased by 46% to $427,115 from $292,118 in the prior year.
• Revenue for the six months ended October 31, 2025, increased by 33% to $531,014 from $400,595 in the prior year.
• Gross profit for the three months ended October 31, 2025, rose by 67% to $260,803, with gross profit margin improving to 61% from 53%.
• Gross profit for the six months ended October 31, 2025, rose by 44% to $329,584, with gross profit margin improving to 62% from 57%.
• Net income for the three months ended October 31, 2025, was $35,810, up from $32,647 in the prior year.
• Net loss for the six months ended October 31, 2025, significantly narrowed to $10,491 from $22,564 in the prior year.
• The dietary supplement products segment was the primary driver of revenue growth, contributing $420,626 (3 months) and $520,300 (6 months) in revenue for the current periods.
• The Consulting Service Segment generated $6,489 (3 months) and $10,714 (6 months) in revenue but incurred segment losses of $(132,959) and $(215,801) respectively.
• Cash from operating activities saw a substantial improvement, turning positive at $476,471 for the six months ended October 31, 2025, compared to a negative $495,241 in the prior year.
• Cash balance increased to $1,259,281 as of October 31, 2025, from $782,810 as of April 30, 2025.
• General and administrative expenses increased significantly by 198% ($79,337) for the three months and 90% ($88,058) for the six months, primarily due to higher legal and professional fees.
• Personnel and benefit costs decreased due to lower salaries for key management personnel.

Sentiment

Score: 6

Explanation: The company demonstrated strong revenue growth and improved profitability, particularly driven by its dietary supplement segment, and a significant turnaround in operating cash flow. However, the identified material weaknesses in internal controls, high customer and vendor concentration, and the consulting segment's ongoing losses present notable concerns and risks.

Positives

• Significant revenue growth of 46% for the quarter and 33% for the six-month period, primarily driven by the dietary supplement products segment.
• Improved gross profit margins, reaching 61% for the quarter and 62% for the six-month period, indicating better product mix or pricing.
• Net income increased for the quarter, and the net loss for the six-month period significantly narrowed, demonstrating improved profitability.
• Strong positive cash flow from operating activities of $476,471 for the six months, a substantial turnaround from a negative cash flow in the prior year.
• Increased cash balance to $1,259,281, enhancing liquidity.
• Decrease in personnel and benefit costs due to lower key management salaries.

Negatives

• The Consulting Service Segment continues to operate at a significant loss, with segment losses of $(132,959) for the quarter and $(215,801) for the six months.
• General and administrative expenses increased substantially by 198% for the quarter and 90% for the six months, mainly due to higher legal and professional fees.
• Identified material weaknesses in internal controls over financial reporting, including a lack of a functioning audit committee and ineffective controls over period-end financial disclosure.
• A significant portion of the company's cash ($424,210 as of October 31, 2025) is uninsured by FDIC.
• High customer concentration, with three major customers accounting for over 60% of revenue in both the three and six-month periods ended October 31, 2025.
• 100% vendor concentration for purchase costs in both periods.

Risks

• Limited Operating History: The company is in a start-up stage with limited historical financial information to evaluate performance and no guarantee of business success.
• Need for Additional Capital: Business is subject to risks inherent in new enterprises, including limited capital resources and possible cost overruns, suggesting a potential future need for capital.
• Material Weaknesses in Internal Controls: Lack of a functioning audit committee and ineffective controls over period-end financial disclosure and reporting processes could lead to material misstatements in future financial statements.
• Cash Concentration Risk: A significant portion of cash ($424,210 as of October 31, 2025) is uninsured by FDIC, exposing the company to potential losses if the holding bank becomes insolvent.
• Customer Concentration Risk: Reliance on a few major customers (over 60% of revenue from three customers) makes the company vulnerable to the loss of any of these customers or changes in their purchasing patterns.
• Vendor Concentration Risk: 100% of purchase costs are from a single vendor, creating dependency and potential supply chain risks.
• Geographic Concentration Risk: Revenue has shifted significantly to the United States, making the company highly dependent on the U.S. market.

Future Outlook

Management continues to look for other opportunities which could potentially increase the profits of the company in 2025. The company's present policy is to apply cash to investments in product development, acquisitions or expansion, and does not expect to pay dividends on Common Stock in the foreseeable future.

Management Comments

• Our revenue significantly increased... due to the commencement of business of the dietary supplement products segment.
• The increase in gross profit margin... is primarily attributable to the more types of dietary supplement products were sold.
• The decrease in personnel and benefit costs... is primarily attributable to the decrease in the salaries of key management personnel.
• The increase in general and administrative expenses is primarily attributable to an increase in legal and professional fees.
• Management believes that the material weaknesses set forth above did not have an effect on our financial results.
• Management believes that the lack of a functioning audit committee and the lack of a majority of outside directors on our Board of Directors results in ineffective oversight in the establishment and monitoring of required internal controls and procedures, which could result in a material misstatement in our financial statements in future periods.
• We expect that once these measures [to remediate material weaknesses] are fully implemented and operating for a sufficient period, we will remediate the identified weaknesses.

Industry Context

The company's strong revenue growth is primarily driven by its dietary supplement segment, indicating a successful entry or expansion into the health and wellness market. This aligns with broader industry trends of increasing consumer demand for health-related products. However, the consulting segment's continued losses suggest challenges in that market or the company's competitive positioning within it.

Corporate Governance

Legal Proceedings

• The company is not currently a party to any legal proceedings and is not aware of any pending or potential legal actions.

Related Party Transactions

• Share-based compensation granted to Chief Financial Officer Steve Niu (60,000 common stocks at $0.05 per share, vesting over one year).
• Proceeds from a related party of $125,000 in financing activities for the six months ended October 31, 2024.

Stakeholder Impact

• Shareholders: Positive financial results (revenue growth, narrowed loss, positive operating cash flow) could be beneficial, but material weaknesses in internal controls and concentration risks pose potential long-term concerns.
• Employees: Decrease in personnel and benefit costs suggests potential salary adjustments or workforce changes, particularly for key management.
• Customers: High customer concentration means the company is highly dependent on a few key customers, which could impact service levels or pricing if relationships change.
• Suppliers: 100% vendor concentration creates dependency on a single supplier, potentially affecting supply chain stability and costs.
• Creditors: Improved cash position and operating cash flow enhance the company's ability to meet short-term obligations, but the consulting segment's losses and internal control issues could be a concern.

Next Steps

• Implement more formal procedures for preparing and reviewing period-end financial statements and disclosures to remediate identified material weaknesses in internal controls.
• Continue to look for other opportunities to increase company profits.
• Apply cash to investments in product development, acquisitions, or expansion.

Key Dates

Recommendation

While Yijia Group Corp. demonstrated impressive revenue growth and a significant turnaround in operating cash flow, primarily driven by its dietary supplement segment, the identified material weaknesses in internal controls over financial reporting, coupled with high customer and vendor concentration, introduce considerable uncertainty and risk. The consulting segment's continued losses also warrant caution. The positive financial momentum is encouraging, but the governance and operational risks suggest a 'hold' position until there is clear evidence of remediation of internal control issues and diversification of revenue and supply chain dependencies.

Keywords

Dietary Supplements, Consulting Services, Financial Performance, SEC 10-Q, Internal Controls, Revenue Growth, Net Income, Cash Flow, Corporate Governance, Risk Factors, NutriPeak Trading Corporation, Healthcare Products, Financial Reporting